Additionally, the activation of HSCs through the angiotensin II type 1 receptor has been shown to promote fibrogenesis and elevate intrahepatic vascular resistance, exacerbating cirrhosis-related complications [232]. This evidence concerns the gene AGTR1 and Cirrhosis.